Show
Sort by
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases
-
- Journal Article
- A1
- open access
Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]
-
- Journal Article
- A1
- open access
Burden of disease in chronic rhinosinusitis with nasal polyps
-
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
-
International consensus statement on allergy and rhinology : rhinosinusitis 2021
-
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial
-
Late breaking abstract : add-on mepolizumab for chronic rhinosinusitis with nasal polyps : SYNAPSE study
-
Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study